Rznomics
Search results
Scope
Date
~
-
Bio & PharmaSouth Korea’s Rznomics inks $1.3 bn out-licensing deal with Eli Lilly
Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lill...
May 16, 2025 (Gmt+09:00)
1
Latest News
- 1 Lee Jae-myung to meet with top business leaders next week ahead of G7 summit
- 2 Korea to allow non-profits to buy consumer bad loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet
